Literature DB >> 2745772

MR imaging in progressive supranuclear palsy and Shy-Drager syndrome.

M Savoiardo1, L Strada, F Girotti, L D'Incerti, M Sberna, P Soliveri, L Balzarini.   

Abstract

Previous reports have suggested that putaminal hypointensity in T2-weighted images at high field strength (1.5 T) magnetic resonance (MR) is a common finding in atypical parkinsonian syndromes, including progressive supranuclear palsy (PSP) and Shy-Drager syndrome (SDS). We have reviewed nine patients with PSP and five with SDS, selected on strict clinical criteria. Only in one PSP patient was abnormal signal intensity (putaminal hypointensity more marked than pallidal) found. However, hypointensity was often marked in the substantia nigra and occasionally in the superior colliculi. Focal midbrain atrophy, involving particularly the upper part of the quadrigeminal plate, was obvious in five cases. In general there was no uniformity of findings and MR appears unable to consistently support the clinical diagnosis of PSP. In SDS patients the findings were more uniform, with hypointensity in the putamen, superior or equal to that of the pallidum. At low or intermediate field strength, there was absence of magnetic susceptibility effect in the putamen, which appeared hyperintense. This was probably because of increased water content due to gliosis and/or cell loss. The constancy of the MR findings in our SDS series suggests a supportive diagnostic role for MR imaging.

Entities:  

Mesh:

Year:  1989        PMID: 2745772     DOI: 10.1097/00004728-198907000-00001

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  14 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Magnetic resonance imaging in progressive supranuclear palsy.

Authors:  M Stamelou; S Knake; W H Oertel; G U Höglinger
Journal:  J Neurol       Date:  2010-12-22       Impact factor: 4.849

3.  Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.

Authors:  H Karbe; M Grond; M Huber; K Herholz; J Kessler; W D Heiss
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

4.  Dementia and movement disorders.

Authors:  D Dormont; D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-01       Impact factor: 3.825

5.  Progressive supranuclear palsy: MRI and pathological findings.

Authors:  A Yagishita; M Oda
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

6.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Authors:  I Litvan; C A Mangone; A McKee; M Verny; A Parsa; K Jellinger; L D'Olhaberriague; K R Chaudhuri; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

7.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.

Authors:  J B Schulz; T Klockgether; D Petersen; M Jauch; W Müller-Schauenburg; S Spieker; K Voigt; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

8.  MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease.

Authors:  Andrea Righini; Angelo Antonini; Roberta De Notaris; Elena Bianchini; Nicoletta Meucci; Giorgio Sacilotto; Margherita Canesi; Danilo De Gaspari; Fabio Triulzi; Gianni Pezzoli
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

9.  Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure.

Authors:  M J Fulham; R M Dubinsky; R J Polinsky; R A Brooks; R T Brown; M T Curras; S Baser; M Hallett; G Di Chiro
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

10.  Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy.

Authors:  M Konagaya; Y Konagaya; M Iida
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.